Market Research Report
North America Atherectomy Devices Market (2019-2025)
|Published by||KBV Research||Product code||914152|
|Published||Content info||61 Pages
Delivery time: 1-2 business days
|North America Atherectomy Devices Market (2019-2025)|
|Published: September 30, 2019||Content info: 61 Pages||
The North America Atherectomy Devices Market would witness market growth of 6.15% CAGR during the forecast period (2019-2025). The North America Atherectomy Devices market is studied across the U.S., Canada, and Mexico. The growing acceptance of minimally invasive processes for atherectomy will increase the demand for atherectomy devices. Such variables fuel the demand for directional atherectomy devices along with the worldwide existence of medical devices across advanced and developing markets. It is anticipated that North America will have the largest market share. Factors like increased accessibility of reimbursements for atherectomy technologies, acceptance of atherectomy systems among medical professionals, large peripheral and coronary artery disease patient population, and a growing amount of clinical trials are pushing North American development rates.
The main factors for dominance of North America Region are the appropriate reimbursement scenario and a significant amount of FDA-approved devices. For example, Avinger, Inc. received 510(k) clearance from the FDA for an image-guided atherectomy system for Pantheris SV (Small Vessel) in April 2019. The Pantheris market is anticipated to have a product range extension of its Lumivascular image-guided atherectomy system by 50%, thus improving its stake in the worldwide market for atherectomy devices.
Rising requirement for vascular and coronary intervention is anticipated to fuel the market for atherectomy devices in the coming years due to growing instances of Peripheral Artery Diseases (PADs) and Coronary Artery Diseases (CADs) in latest years. In the recent past, even among older people, cases of diabetes, critical limb ischemia and cardiovascular diseases have risen. The growing frequency of vascular illnesses and diseases linked to or caused by calcified peripheral and coronary arteries reduced blood flow and lower-limb amputation are estimated to boost the demand for atherectomy devices over the prediction era and are concurrently expected to improve at a stable pace over the coming years.
Based on Type, the market is segmented into Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy and Laser Atherectomy. Based on Regions, the North America market is segmented into USA, Canada, Mexico and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardiovascular Systems Inc., Avinger Inc., Straub Medical AG, Boston Scientific Corporation, Medtronic PLC (Covidien), Koninklijke Philips N.V., Cardinal Health, Inc. (Cordis), Terumo Corporation (Terumo IS), Abbott Laboratories and B. Braun Melsungen AG.